Alyeska Investment Group
ABEO icon

Alyeska Investment Group’s Abeona Therapeutics ABEO Stock Holding History

Alyeska Investment Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-70,000
Closed -$297K – 511
2024
Q2 		$297K Buy
+70,000
New +$357K ﹤0.01% 519
2024
Q1 		– Sell
-70,000
Closed -$351K – 445
2023
Q4 		$351K Buy
+70,000
New +$308K ﹤0.01% 454
2023
Q3 		– Sell
-70,000
Closed -$282K – 475
2023
Q2 		$282K Buy
+70,000
New +$245K ﹤0.01% 516

Other funds holding ABEO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return